Skip to main content
. 2018 Dec 6;8:555. doi: 10.3389/fonc.2018.00555

Table 1.

Clinical characteristics on the 20 patients enrolled into the study.

Clinical feature n (%)
Patients 20
Age (median/range) 64 (56–79)
SEX
M 11 (55)
F 9 (45)
SOKAL RISK SCORE
Low 7 (35)
Intermediate 9 (45)
High 4 (20)
TKI
Imatinib 20 (100%)